IL154711A0 - Methods of producing polymorphic crystals of donepezil hydrochloride - Google Patents

Methods of producing polymorphic crystals of donepezil hydrochloride

Info

Publication number
IL154711A0
IL154711A0 IL15471101A IL15471101A IL154711A0 IL 154711 A0 IL154711 A0 IL 154711A0 IL 15471101 A IL15471101 A IL 15471101A IL 15471101 A IL15471101 A IL 15471101A IL 154711 A0 IL154711 A0 IL 154711A0
Authority
IL
Israel
Prior art keywords
producing polymorphic
donepezil hydrochloride
methods
ylümethylpiperidine
indanon
Prior art date
Application number
IL15471101A
Other languages
English (en)
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of IL154711A0 publication Critical patent/IL154711A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Cephalosporin Compounds (AREA)
IL15471101A 2000-09-25 2001-09-17 Methods of producing polymorphic crystals of donepezil hydrochloride IL154711A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000289956 2000-09-25
JP2000322184 2000-10-23
PCT/JP2001/008057 WO2002026709A1 (fr) 2000-09-25 2001-09-17 Procede servant a preparer un cristal multiforme d'hydrochlorure de donepezil

Publications (1)

Publication Number Publication Date
IL154711A0 true IL154711A0 (en) 2003-10-31

Family

ID=26600625

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15471101A IL154711A0 (en) 2000-09-25 2001-09-17 Methods of producing polymorphic crystals of donepezil hydrochloride
IL154711A IL154711A (en) 2000-09-25 2003-03-03 Methods of producing polymorphic crystals of donepezil hydrochloride

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL154711A IL154711A (en) 2000-09-25 2003-03-03 Methods of producing polymorphic crystals of donepezil hydrochloride

Country Status (9)

Country Link
US (2) US20040034057A1 (ja)
EP (1) EP1323712B1 (ja)
JP (1) JPWO2002026709A1 (ja)
AT (1) ATE369340T1 (ja)
AU (1) AU2001286260A1 (ja)
DE (1) DE60129828T2 (ja)
ES (1) ES2288984T3 (ja)
IL (2) IL154711A0 (ja)
WO (1) WO2002026709A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4521682B2 (ja) * 2002-07-24 2010-08-11 佐竹化学機械工業株式会社 晶析装置の結晶粒度制御装置
WO2006011154A1 (en) * 2004-07-28 2006-02-02 Usv Limited A novel polymorph of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine hydrochloride (donepezil hydrochloride) and a process for producing thereof
US7186842B2 (en) 2003-02-12 2007-03-06 Usv, Ltd. Polymorph of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-y1] methyl piperidine hydrochloride (Donepezil hydrochloride) and a process for producing thereof
US7560560B2 (en) 2003-04-16 2009-07-14 Hetero Drugs Limited Crystalline forms of donepezil hydrochloride
JP4748449B2 (ja) * 2003-11-27 2011-08-17 味の素株式会社 フェニルアラニン誘導体の結晶及びその製造方法
US20070123565A1 (en) * 2004-07-23 2007-05-31 Aher Umesh P Donepezil Hydrochloride Form VI
JP2008514691A (ja) * 2004-09-29 2008-05-08 ケマジス リミティド 薬学的に純粋な非晶質塩酸ドネペジルを製造するための精製されたマレイン酸ドネペジルの使用
US20060122226A1 (en) 2004-12-08 2006-06-08 Itai Adin Crystalline forms of Donepezil base
WO2007108011A2 (en) * 2006-03-20 2007-09-27 Ind-Swift Laboratories Limited Process for the preparation of highly pure donepezil
WO2009084030A2 (en) * 2007-12-03 2009-07-09 Neuland Laboratories Ltd. Improved process for the preparation of (1-benzyl-4-(5,6,- dimethoxyind anone-2-yl)methylpiperidine) hydrochloride-form iii
JP5562337B2 (ja) * 2008-12-17 2014-07-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 ドネペジルの多形結晶及びその製造方法
WO2011061591A1 (en) * 2009-11-18 2011-05-26 Jubilant Life Sciences Limited Improved process for the preparation of 1-benzyl-4-(5,6-dimethoxy-1-indanone)-2-yl)methyl piperidine hydrochloride form-iii
EP2366378A1 (en) 2010-03-01 2011-09-21 Dexcel Pharma Technologies Ltd. Sustained-release donepezil formulations
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1053576A (ja) * 1996-06-07 1998-02-24 Eisai Co Ltd 塩酸ドネペジルの多形結晶およびその製造法
TW513409B (en) * 1996-06-07 2002-12-11 Eisai Co Ltd Polymorphs of donepezil hydrochloride
AU1153097A (en) * 1996-06-07 1998-01-05 Eisai Co. Ltd. Stable polymorphs of donepezil (1-benzyl-4-{(5,6-dimethoxy-1-indanon)-2-yl}methylpiperidine ) hydrochloride and process for production

Also Published As

Publication number Publication date
WO2002026709A1 (fr) 2002-04-04
DE60129828T2 (de) 2008-04-30
US20050209281A1 (en) 2005-09-22
EP1323712A1 (en) 2003-07-02
DE60129828D1 (de) 2007-09-20
US7479563B2 (en) 2009-01-20
ES2288984T3 (es) 2008-02-01
US20040034057A1 (en) 2004-02-19
IL154711A (en) 2009-05-04
EP1323712B1 (en) 2007-08-08
JPWO2002026709A1 (ja) 2004-02-05
AU2001286260A1 (en) 2002-04-08
EP1323712A4 (en) 2004-07-21
ATE369340T1 (de) 2007-08-15

Similar Documents

Publication Publication Date Title
IL154711A0 (en) Methods of producing polymorphic crystals of donepezil hydrochloride
HK1020194A1 (en) Crystals of benzimidazole derivatives and their production
NO934501L (no) Karboksylsyrederivater, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling
DE69531624D1 (de) Verfahren zur herstellung von levobupivacaine und analoge
ATE450497T1 (de) Formoteroltartrat verfahren und polymorph
FI904035A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia 4-substituoituja 17 -(syklopropyyliamino)androst-5-eenijohdannaisia, jotka ovat hyödyllisiä C17-20-lyaasi-inhibiittoreina
MY126689A (en) Process for the preparation of sulphonamide-substituted imidazotriazinones
HUP0401595A2 (hu) Eljárás 2-halogén-piridinkarboxamidok előállítására
WO2002066429A8 (de) Verfahren zur herstellung von nicht hydratisiertem fexofenadin-hydrochlorid und eine so erhaetliche neue kristalline form
HK1042309A1 (en) Method of producing a polymer network.
EP1327626A4 (en) PRAVASTATIN PURIFICATION PROCESS
HRP20050501A2 (en) Method for producing salts of tolperisone
HUP0103754A2 (hu) Diuridin-tetrafoszfátnak vagy sójának kristályos formája és eljárás a kristályos forma és a vegyület előállítására
ATE356115T1 (de) Verfahren zur herstellung von 1-benzyl-4- (5,6- dimethoxy-1-indanon)-2-ylö methylpiperidin hydrochlorid (donepezil hcl)
GEP20033119B (en) Novel Octahydro-6, 10-Dioxo-6H-Pyridazino {1,2-a}{1 Carboxylic Acid Derivatives, Method for Preparation and Use Thereof
EA200300749A1 (ru) Микробиологический способ получения амидов
ATE270287T1 (de) 2,3-dihydro-1h-isoindolderivate, verfahren zu ihrer herstellung und ihre verwendung als hemmer der serotoninwiederaufnahme
ES2082703A1 (es) Nuevos derivados de ciclopropilo, procedimientos para su preparacion y aplicaciones.
WO2003068726A1 (fr) Derive amide d'amine alicyclique et procede de production de celui-ci
WO2001042182A3 (de) Verfahren zur herstellung von o-chlormethylbenzoesäurechloriden
WO2004080583A3 (en) PROCESS FOR THE PREPARATION OF threo-METHYLPHENIDATE HYDROCHLORIDE
AU2002333879A1 (en) Method for producing vanillylamine hydrochloride
IL149748A0 (en) Method for production of 1,3-disubstituted 2-nitroguanidines
ATE321028T1 (de) Verfahren zur herstellung von 1,3- disubstituierten 2-nitroguanidinen
DE69532641D1 (de) Verfahren und zwischenprodukte zur herstellung von 5,7-dihydro-3-(2 1-benzylpiperidin-4-yl ethyl)-6h-pyrrolo-(4,5-f)-1,2-benzisoxazol-6-on